We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$61.5B
1-Year Est. Return
30.7%
This Fund
S&P 500
This Quarter
Est. Return
+1.04%
1 Year Est. Return
+30.7%
3 Year Est. Return
+96.89%
5 Year Est. Return
+121.97%
10 Year Est. Return
+542.41%
AUM
$52.5B
AUM Growth
-$1.16B
(-2.2%)
Cap. Flow
-$491M
Cap. Flow
% of AUM
-0.94%
Top 10 Holdings %
Top 10 Hldgs %
12.04%
Holding
2,386
New
193
Increased
800
Reduced
1,005
Closed
184
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
GXO Logistics
GXO
|
+$161M |
| 2 |
Invivyd
IVVD
|
+$94.7M |
| 3 |
Freeport-McMoran
FCX
|
+$88.6M |
| 4 |
Amgen
AMGN
|
+$87.7M |
| 5 |
Truist Financial
TFC
|
+$83.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Moderna
MRNA
|
+$296M |
| 2 |
Pfizer
PFE
|
+$276M |
| 3 |
Cisco
CSCO
|
+$151M |
| 4 |
TBIO
Translate Bio, Inc. Common Stock
TBIO
|
+$103M |
| 5 |
Evergy
EVRG
|
+$99.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.42% |
| 2 | Technology | 20.59% |
| 3 | Financials | 12.18% |
| 4 | Consumer Discretionary | 9.07% |
| 5 | Industrials | 7.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
376
Allegion
ALLE
$13.5B
| $31.3M | 0.06% |
237,000
+90,239
| +61% | +$12.5M |
|
|
HZNP
377
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $31M | 0.06% |
282,724
-76,938
| -21% | -$7.99M |
|
378
McDonald's
MCD
$193B
| $31M | 0.06% |
128,425
+5,985
| +5% | +$1.43M |
|
379
Bright Horizons
BFAM
$4.35B
| $30.7M | 0.06% |
220,376
+1,456
| +0.7% | +$214K |
|
|
SKX
380
DELISTED
Skechers
SKX
| $30.7M | 0.06% |
728,395
-11,264
| -2% | -$557K |
|
381
UGI
UGI
$7.87B
| $30.6M | 0.06% |
718,218
-42,003
| -6% | -$1.92M |
|
|
PXD
382
DELISTED
Pioneer Natural Resource Co.
PXD
| $30.5M | 0.06% |
183,441
-1,659
| -0.9% | -$251K |
|
383
Sprout Social
SPT
$530M
| $30.4M | 0.06% |
249,446
+41,383
| +20% | +$4.49M |
|
384
Sarepta Therapeutics
SRPT
$1.64B
| $30.4M | 0.06% |
328,941
+102,858
| +45% | +$7.92M |
|
|
NAPA
385
DELISTED
The Duckhorn Portfolio, Inc.
NAPA
| $30.4M | 0.06% |
1,328,373
| – | – |
|
386
Telus
TU
$17.4B
| $30.4M | 0.06% |
1,382,375
-76,907
| -5% | -$1.73M |
|
387
Robert Half
RHI
$4.11B
| $30.2M | 0.06% |
300,536
-1,596
| -0.5% | -$156K |
|
388
Genmab
GMAB
$17.5B
| $30.1M | 0.06% |
689,061
-6,561
| -0.9% | -$295K |
|
389
Intel
INTC
$413B
| $30M | 0.06% |
563,890
-3,083
| -0.5% | -$167K |
|
|
AKUS
390
DELISTED
Akouos Inc
AKUS
| $29.8M | 0.06% |
2,570,780
| – | – |
|
391
DXC Technology
DXC
$1.91B
| $29.8M | 0.06% |
885,758
-239,374
| -21% | -$9.06M |
|
|
UNIT
392
Uniti Group
UNIT
$2.52B
| $29.6M | 0.06% |
2,390,674
-19,846
| -0.8% | -$242K |
|
|
CFRX
393
DELISTED
ContraFect Corporation
CFRX
| $29.6M | 0.06% |
91,215
| – | – |
|
394
Jacobs Solutions
J
$16B
| $29.5M | 0.06% |
269,073
+54,879
| +26% | +$6.07M |
|
395
Century Therapeutics
IPSC
$364M
| $29.3M | 0.06% |
1,164,094
+614,094
| +112% | +$16.6M |
|
396
Asana
ASAN
$1.96B
| $29.3M | 0.06% |
281,712
+155,693
| +124% | +$12.9M |
|
|
AYX
397
DELISTED
Alteryx Inc
AYX
| $29.2M | 0.06% |
400,000
| – | – |
|
398
Dynatrace
DT
$12.7B
| $28.9M | 0.06% |
406,933
+37,659
| +10% | +$2.47M |
|
399
Dropbox
DBX
$7.78B
| $28.5M | 0.05% |
974,865
+17,077
| +2% | +$530K |
|
400
Globant
GLOB
$1.65B
| $28.5M | 0.05% |
101,348
+32,573
| +47% | +$8.94M |
|
Similar funds
Federated Hermes's Q3 2021 Portfolio in Review
As of Q3 2021, Federated Hermes held 2,386 positions worth $52.5B, down 2.2% from $53.7B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Federated Hermes's Q3 2021 filing shows 193 new, 800 increased, 1,005 reduced and 184 closed positions. Its largest new stake was GXO Logistics: 2,051,695 shares worth $161M. The largest sale was Moderna, an estimated $296M.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, up from 21% a quarter earlier, followed by Technology and Financials.
- Federated Hermes's largest Q3 2021 buy was GXO Logistics: 2,051,695 shares worth $161M.
- Federated Hermes added most to Freeport-McMoran in Q3 2021, an estimated $88.6M increase.
- Federated Hermes's biggest Q3 2021 reduction was Moderna, cutting an estimated $296M.
- Federated Hermes fully exited Translate Bio, Inc. Common Stock in Q3 2021, selling an estimated $103M.
- Federated Hermes's ten largest holdings make up 12% of its $52.5B portfolio in Q3 2021.
- Federated Hermes opened 193 new positions and closed 184 in Q3 2021.
- Federated Hermes's portfolio value fell 2.2% quarter-over-quarter to $52.5B.
Based on Federated Hermes's 13F filing for Q3 2021, filed 15 Nov 2021.